Literature DB >> 20300990

Quantitative RT-PCR methods for mature microRNA expression analysis.

Stephanie D Fiedler1, Martha Z Carletti, Lane K Christenson.   

Abstract

This chapter describes two methods to measure expression of mature miRNA levels using qRT-PCR. The first method uses stem-loop RT primers to produce cDNA for specific miRNAs, a technique that our laboratory has modified to increase the number of miRNAs being reverse transcribed within a single RT reaction from one (as suggested by the manufacturer) to five. The second method uses a modified oligo(dT) technique to reverse transcribe all transcripts within an RNA sample; therefore, target miRNA and normalizing mRNA can be analyzed from the same RT reaction. We examined the level of miRNA-132, a miRNA known to be upregulated in granulosa cells following hCG treatment, using both of these methods. Data were normalized to GAPDH or snU6 and evaluated by DeltaDeltaCt and standard curve analysis. There was no significant difference (P > 0.05) in miRNA-132 expression between the stem-loop and modified oligo(dT) RT methods indicating that both are statistically equivalent. However, from a technical point of view, the modified oligo(dT) method was less time consuming and required only a single RT reaction to reverse transcribe both miRNA and mRNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20300990     DOI: 10.1007/978-1-60761-629-0_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  28 in total

1.  Identification of microRNA-like RNAs in a plant pathogenic fungus Sclerotinia sclerotiorum by high-throughput sequencing.

Authors:  Jiahong Zhou; Yanping Fu; Jiatao Xie; Bo Li; Daohong Jiang; Guoqing Li; Jiasen Cheng
Journal:  Mol Genet Genomics       Date:  2012-04       Impact factor: 3.291

2.  Role of microRNA-21 and programmed cell death 4 in the pathogenesis of human uterine leiomyomas.

Authors:  J Browning Fitzgerald; Vargheese Chennathukuzhi; Faezeh Koohestani; Romana A Nowak; Lane K Christenson
Journal:  Fertil Steril       Date:  2012-06-22       Impact factor: 7.329

3.  miR-124-9-9* potentiates Ascl1-induced reprogramming of cultured Müller glia.

Authors:  Stefanie Gabriele Wohl; Thomas Andrew Reh
Journal:  Glia       Date:  2016-01-06       Impact factor: 7.452

Review 4.  Epigenetics of progression of chronic kidney disease: fact or fantasy?

Authors:  Maria R Wing; Ali Ramezani; Harindarpal S Gill; Joseph M Devaney; Dominic S Raj
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

Review 5.  Current approaches to micro-RNA analysis and target gene prediction.

Authors:  Tenzin W Lhakhang; M Ahmad Chaudhry
Journal:  J Appl Genet       Date:  2011-09-03       Impact factor: 3.240

6.  Multiplexed fluorometric determination for three microRNAs in acute myocardial infarction by using duplex-specific nuclease and MoS2 nanosheets.

Authors:  Xue Zhu; Ke Wang; Yan Jin; Shuya Wang; Xiaoxiao Liu; Haohao Liu; Peiling Zhou; Chengjian Yang; Zhijun Han
Journal:  Mikrochim Acta       Date:  2019-12-04       Impact factor: 5.833

Review 7.  MicroRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Hoell; Pavel Morozov; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy.

Authors:  Vlastimil Kulda; Martin Svaton; Petr Mukensnabl; Kristyna Hrda; Pavel Dvorak; Zbynek Houdek; Katerina Houfkova; Radana Vrzakova; Vaclav Babuska; Milos Pesek; Martin Pesta
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

Review 9.  miRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Spitzer; Pavel Morozov; Thomas Tuschl
Journal:  J Pathol       Date:  2010-11-18       Impact factor: 7.996

10.  Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing.

Authors:  Markus Hafner; Neil Renwick; Thalia A Farazi; Aleksandra Mihailović; John T G Pena; Thomas Tuschl
Journal:  Methods       Date:  2012-08-07       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.